Nuvectis Pharma (NVCT) Margins & Profitability 2022-2026
Gross, EBITDA, operating, and net margin trends
Margins
Profit margins across the income statement
- EBITDA Margin
- N/A
- Op. Margin
- -3104900000.0% 298.4%
- Net Margin
- -3007000000.0% 303.0%
Gross Margin (%)
Revenue left after direct cost of goods sold
EBITDA Margin (%)
Operating profitability independent of capital structure
Operating & Net Margins (%)
How much of each dollar becomes profit